Patent · US Active

Vaccinia capping enzyme compositions and methods

US12312610B2 · kind B2 · utility

0Cited by
12References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 7, 2023
Grant dateMay 27, 2025
Priority date
Expiry dateSep 7, 2043

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Y207/0705
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present disclosure relates, according to some embodiments, to compositions, methods, and/or kits for producing vaccinia capping enzyme. For example, active, heterodimers of vaccinia capping enzyme may be produced as fusions comprising D1 and D12 subunits. Vaccinia capping enzyme fusion proteins may further comprise a linker.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.